Department of Endocrinology, Diabetology and Nutrition, University Hospital Centre Nancy, Vandoeuvre-lès-Nancy, France.
Faculty of Medicine, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Clin Endocrinol (Oxf). 2019 Jul;91(1):10-21. doi: 10.1111/cen.13982. Epub 2019 Apr 17.
The majority of transgender and gender nonconforming persons seeking medical care are of reproductive age. Hormonal treatment and sex reassignment surgery, which are used in the management of gender dysphoria, compromise fertility potential. Children and adolescents with gender dysphoria have specific treatment regimens starting with puberty-blocking medications. According to international guidelines, fertility preservation should be discussed before any hormonal treatment, although our knowledge on the reproductive needs of transgender and gender nonconforming persons is limited. Recently, some data have emerged on fertility management in some centres for the adult population with gender dysphoria. The goal of this review was to summarize the available evidence on the fertility desires and parental roles of transgender and gender nonconforming people. In light of newly emerging societal challenges, we aim to provide some considerations for clinical practice and suggest further areas of research.
大多数寻求医疗护理的跨性别和性别不一致者都处于生育年龄。用于治疗性别焦虑症的激素治疗和性别重置手术会影响生育潜能。患有性别焦虑症的儿童和青少年从青春期阻滞剂开始有特定的治疗方案。根据国际指南,在进行任何激素治疗之前,都应讨论生育力保存问题,尽管我们对跨性别和性别不一致者的生殖需求了解有限。最近,一些关于某些中心的性别焦虑症成年人口的生育力管理的数据已经出现。本综述的目的是总结有关跨性别和性别不一致者的生育愿望和父母角色的现有证据。鉴于新出现的社会挑战,我们旨在为临床实践提供一些考虑因素,并提出进一步的研究领域。